STATE STREET CORP - INOZYME PHARMA INC ownership

INOZYME PHARMA INC's ticker is INZY and the CUSIP is 45790W108. A total of 78 filers reported holding INOZYME PHARMA INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE STREET CORP ownership history of INOZYME PHARMA INC
ValueSharesWeighting
Q3 2023$2,639,057
-15.5%
628,347
+12.0%
0.00%
Q2 2023$3,123,890
+456.0%
560,842
+472.0%
0.00%
Q1 2023$561,855
+250.4%
98,055
-35.8%
0.00%
Q4 2022$160,346
-21.8%
152,710
+100.0%
0.00%
Q3 2022$205,000
-12.4%
76,355
+55.7%
0.00%
Q2 2022$234,000
-69.7%
49,055
-74.0%
0.00%
Q1 2022$773,000
-39.4%
189,005
+1.0%
0.00%
Q4 2021$1,276,000
-41.5%
187,102
-0.6%
0.00%
Q3 2021$2,182,000
-24.6%
188,267
+10.8%
0.00%
Q2 2021$2,895,000
+10.6%
169,889
+28.5%
0.00%
Q1 2021$2,618,000
+7.9%
132,219
+12.5%
0.00%
Q4 2020$2,427,000
+30.8%
117,579
+66.6%
0.00%
Q3 2020$1,856,00070,5850.00%
Other shareholders
INOZYME PHARMA INC shareholders Q3 2023
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 1,591,154$10,852,0004.54%
CHI Advisors LLC 892,057$6,084,0002.02%
Sofinnova Investments, Inc. 2,028,308$13,833,0000.81%
MPM BioImpact LLC 302,615$2,064,0000.38%
NEA Management Company, LLC 2,444,379$16,671,0000.34%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,344,786$15,991,0000.34%
Rock Springs Capital Management LP 868,466$5,923,0000.14%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,013,216$6,910,0000.13%
Orbimed Advisors 526,600$3,591,0000.05%
Overbrook Management Corp 16,726$114,0000.02%
View complete list of INOZYME PHARMA INC shareholders